Protaminsulfat LEO Pharma 1400 Heparin-Antidot I.E./ml, Injektionslösung und Infusionslösung
7680698420019
CH-69842
Injektionslösung
Associated product:
PROTAMINSULFAT LEO Pharma 1400 Heparin Antidot I.E
1 / 3
google
Article details
- Package size
- 5 x 5
- Selling units
- 5
- Measure
- ml
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
protamini sulfas
|
1400.0 UI | Substance | Wirkstoff (Principe actif) |
|
protamini sulfas
|
10.0 MG | Substance | WIZUS |
|
natrii chloridum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
3.34 MG | Substance | HBESI |
Authorization holder
Leo Pharmaceutical Products Sarath Ltd.
8302 Kloten
Authorization information
- Swissmedic authorization number
- 69842
- Drug name
- Protaminsulfat LEO Pharma 1400 Heparin-Antidot I.E./ml, Injektionslösung und Infusionslösung
- Galenic form
- LSIN
- ATC Code
- V03AB14
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 17/04/2025
- Authorization expiration date
- 16/04/2030
- IT Number
- 06.04.0.
- Domain
- Human medicine
Package details
- Description (FR)
- PROTAMINSULFAT LEO Pharma 1400 Heparin Antidot I.E
- Description (DE)
- PROTAMINSULFAT LEO Pharma 1400 Heparin Antidot I.E
- Market launch
- 01/12/2025
- Narcotic (BTM)
- No